News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
84,272 Results
Type
Article (6723)
Company Profile (8)
Press Release (77540)
Multimedia
Podcasts (2)
Webinars (3)
Section
Business (21796)
Career Advice (398)
Deals (3209)
Drug Delivery (9)
Drug Development (8032)
Employer Resources (41)
FDA (2658)
Job Trends (1756)
News (35612)
Policy (3142)
Tag
Academia (506)
Accelerated approval (1)
Adcomms (3)
Allergies (11)
Alliances (6459)
ALS (15)
Alzheimer's disease (633)
Antibody-drug conjugate (ADC) (30)
Approvals (2698)
Artificial intelligence (155)
Autoimmune disease (7)
Automation (10)
Bankruptcy (36)
Best Places to Work (1542)
Biosimilars (13)
Biotechnology (7)
Bladder cancer (17)
Brain cancer (13)
Breast cancer (137)
Cancer (651)
Cardiovascular disease (45)
Career advice (338)
Career pathing (2)
CAR-T (16)
CDC (1)
Cell therapy (50)
Cervical cancer (2)
Clinical research (6426)
Collaboration (233)
Compensation (16)
Complete response letters (5)
COVID-19 (467)
CRISPR (4)
C-suite (92)
Cystic fibrosis (8)
Data (713)
Decentralized trials (1)
Depression (11)
Diabetes (40)
Diagnostics (1398)
Digital health (7)
Diversity (2)
Diversity, equity & inclusion (11)
Drug discovery (31)
Drug pricing (6)
Duchenne muscular dystrophy (18)
Earnings (7332)
Editorial (4)
Employer branding (6)
Employer resources (38)
Events (10047)
Executive appointments (103)
FDA (3063)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (2)
Frontotemporal dementia (5)
Funding (150)
Gene editing (8)
Generative AI (11)
Gene therapy (46)
GLP-1 (114)
Government (513)
Guidances (37)
Healthcare (2676)
HIV (3)
Huntington's disease (4)
IgA nephropathy (5)
Immunology and inflammation (16)
Immuno-oncology (1)
Indications (15)
Infectious disease (485)
Inflammatory bowel disease (24)
Inflation Reduction Act (1)
Influenza (11)
Intellectual property (26)
Interviews (78)
IPO (1170)
IRA (2)
Job creations (236)
Job search strategy (269)
JPM (6)
Kidney cancer (4)
Labor market (7)
Layoffs (67)
Leadership (6)
Legal (500)
Liver cancer (17)
Longevity (1)
Lung cancer (71)
Lymphoma (26)
Machine learning (5)
Management (13)
Manufacturing (70)
MASH (20)
Medical device (2655)
Medtech (2665)
Mergers & acquisitions (2112)
Metabolic disorders (95)
Multiple sclerosis (45)
NASH (6)
Neurodegenerative disease (70)
Neuropsychiatric disorders (9)
Neuroscience (813)
Neurotech (1)
NextGen: Class of 2026 (749)
Non-profit (569)
Now hiring (5)
Obesity (35)
Opinion (45)
Ovarian cancer (11)
Pain (16)
Pancreatic cancer (21)
Parkinson's disease (49)
Partnered (8)
Patents (48)
Patient recruitment (42)
Peanut (3)
People (7235)
Pharmaceutical (2)
Pharmacy benefit managers (1)
Phase 1 (1771)
Phase 2 (2864)
Phase 3 (2514)
Pipeline (591)
Policy (14)
Postmarket research (203)
Preclinical (756)
Press Release (6)
Prostate cancer (74)
Radiopharmaceuticals (159)
Rare diseases (64)
Real estate (629)
Recruiting (17)
Regulatory (2595)
Reports (14)
Research institute (418)
Resumes & cover letters (57)
Rett syndrome (2)
RNA editing (2)
RSV (1)
Schizophrenia (11)
Series A (19)
Series B (15)
Sickle cell disease (5)
Special edition (9)
Spinal muscular atrophy (25)
Sponsored (12)
Startups (368)
Stomach cancer (2)
Supply chain (7)
The Weekly (2)
Vaccines (170)
Venture capital (6)
Weight loss (15)
Women's health (12)
Worklife (6)
Date
Last 7 days (56)
Last 30 days (217)
Last 365 days (2990)
2026 (266)
2025 (3117)
2024 (4138)
2023 (5004)
2022 (8744)
2021 (7453)
2020 (6078)
2019 (5866)
2018 (4400)
2017 (3873)
2016 (3821)
2015 (4382)
2014 (3313)
2013 (2864)
2012 (3014)
2011 (3207)
2010 (2800)
Location
Africa (102)
Alabama (2)
Alaska (1)
Arizona (44)
Arkansas (4)
Asia (5094)
Australia (981)
California (906)
Canada (287)
China (56)
Colorado (47)
Connecticut (38)
Delaware (35)
Europe (11586)
Florida (268)
Georgia (43)
Hawaii (1)
Idaho (11)
Illinois (149)
India (4)
Indiana (65)
Iowa (1)
Japan (71)
Kansas (10)
Kentucky (3)
Louisiana (2)
Maine (13)
Maryland (71)
Massachusetts (800)
Michigan (46)
Minnesota (81)
Mississippi (2)
Missouri (13)
Nebraska (2)
Nevada (14)
New Hampshire (20)
New Jersey (267)
New Mexico (10)
New York (304)
North Carolina (104)
North Dakota (1)
Northern California (406)
Ohio (25)
Oklahoma (2)
Oregon (8)
Pennsylvania (165)
Rhode Island (4)
South America (166)
South Carolina (20)
Southern California (380)
Tennessee (20)
Texas (289)
United States (3897)
Utah (42)
Vermont (1)
Virginia (22)
Washington D.C. (5)
Washington State (58)
West Virginia (3)
Wisconsin (24)
84,272 Results for "aspect imaging".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Earnings
AstraZeneca Builds Obesity Pipeline On ‘Medical Aspect,’ Not Aesthetics
In an investor call Thursday, AstraZeneca CEO Pascal Soriot outlined his company’s approach to obesity drug development based on “the medical aspect” of weight loss, including driving down visceral fat.
November 6, 2025
·
2 min read
·
Tristan Manalac
Cell therapy
After Cell Therapy Retreat, Novo Offloads Technologies in Deepened Aspect Pact
Novo Nordisk pulled back from cell therapies last October, scrapping development of a type 1 diabetes therapy and laying off most employees working on this modality.
January 21, 2026
·
2 min read
·
Tristan Manalac
Press Releases
Aspect Biosystems and Novo Nordisk enter new phase of partnership to develop curative medicines for diabetes
January 20, 2026
·
4 min read
Biotech Beach
Aspect Imaging Celebrates First Installation of Embrace® Neonatal MRI System in Canada at The Hospital for Sick Children in Toronto
Aspect Imaging, the leading provider of compact MRI solutions, is proud to announce the successful installation of the Embrace® Neonatal MRI System at The Hospital for Sick Children in Toronto, Ontario, marking a significant milestone as the first installation of its kind in Canada.
March 28, 2024
·
2 min read
Press Releases
Aspect Biosystems Presents New Preclinical Data on Adrenal Bioprinted Tissue Therapeutics at ENDO 2025
July 14, 2025
·
4 min read
Press Releases
TridentCare Announces Acquisition of DispatchHealth’s Imaging Business Unit
January 22, 2026
·
2 min read
Press Releases
Medical-imaging company Imagion Biosystems Lodges IND with FDA for Phase 2 Trial of MagSense® HER2 targeted imaging agent
February 4, 2026
·
2 min read
Biotech Beach
Aspect Imaging Receives Innovative Technology Contract from Vizient for Embrace® Point of Care Neonatal MRI System
Aspect Imaging, LLC, the global leader in disruptive MRI systems for clinically complex neonatal patients announced its Embrace® Point of Care Neonatal MRI System has received an Innovative Technology contract from Vizient, Inc. the nation’s largest provider-driven healthcare performance improvement company.
September 20, 2023
·
3 min read
Press Releases
Maxwell Biosciences Secures US Military Agreement to Research Scientific Aspects of Claromer Technology
U.S. Army Institute of Surgical Research to conduct key studies intended to further our knowledge of the effects of Claromer technology
March 5, 2025
·
2 min read
Press Releases
BriaCell Patients’ Images Show Regression and Resolution of Metastasized Tumors and Immune Activation
January 29, 2026
·
6 min read
1 of 8,428
Next
